Indian AI-native biosolutions company Absolute has begun commercial operations of its agricultural biologicals arm INERA in Kenya, marking its entry into Africa and the first step in a wider expansion across key global farming markets.
INERA has partnered with an established Kenyan agricultural company involved in floriculture, exotic herbs and horticulture to distribute and scale its products locally. Its initial commercial portfolio comprises six biological products focused on Biological Nutrition Management and Plant Physiology & Climate Resilience.
The products include BioMorphX, a patented biostimulant aimed at influencing plant morphology and physiological responses; Phycorise, designed to support pigment development, cell-wall characteristics and post-harvest performance; and Baco L and Baco G, microbial nutrient products combining beneficial bacterial strains with INERA’s STREAC technology. The latter supports biological nitrogen fixation, phosphorus solubilisation and potassium mobilisation.
The Phyro series is designed to improve biological nutrient acquisition, root function and crop resilience, particularly under nutrient- and water-stressed conditions. INERA said the series has already gained acceptance among more than 2 million farmers in India.
Kenya will also serve as a base for the company’s planned expansion into other East and West African markets during 2026 and 2027. Absolute is simultaneously planning to increase its presence in the US and Southeast Asia.
The company said Africa offers significant potential for biological agricultural technologies. According to the African Development Bank, nearly two-thirds of the world’s remaining uncultivated arable land is in Africa, while cereal yields remain below the global average.
Kenya’s agriculture sector contributes about 24% of GDP and supports livelihoods for around 72% of the population. Its horticultural exports were valued at KSh136.6 billion in 2024, including KSh72.1 billion from flowers and about KSh41 billion from fruits.
INERA said it is also developing biological crop-protection technologies based on microbial, peptide and RNAi platforms, although these products are separate from its initial Kenya portfolio.